Relmada Therapeutics, Inc. (OTCQB: RLMD) is a clinical-stage pharmaceutical company developing new versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The company’s portfolio has four lead products at various stages of development including LevoCar ER, its abuse-resistant form of the opioid analgesic levorphanol and d-Methadone, its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain. For more information, visit the company’s website at www.relmada.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.